Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

FCC Adds $198 Million to Strengthen Telehealth for Rural Healthcare Providers

Client Alert

The Federal Communications Commission (“FCC”) has added an additional $198 million in funding to its Rural Health Care Program. These funds will be used to increase broadband services and telecommunications to bolster telehealth/telemedicine services for rural healthcare providers. Funding for rural healthcare providers was initially capped at $605 million in 2020, but the added funds will now allow the FCC to provide over $800 million to eligible providers.

Telehealth, in direct response to the COVID-19 public health emergency, has undergone a massive expansion since March. Telehealth encounters are up exponentially as patients look for a safe, socially distant, option to receive health care services and providers try to keep vital hospital space available for COVID-19 care. Technical barriers, such as the lack of a strong broadband infrastructure, has limited the wide adoption of telehealth in rural areas. The FCC aims to combat the technical limitations, as this funding will help improve technology platforms and internet connectivity, so that patients have expanded access to affordable and efficient care. 

Eligible providers for the Rural Health Care Program include:

  1. post-secondary educational institutions offering health care instruction, teaching hospitals, and medical schools;
  2. community health centers or health centers providing health care to migrants;
  3. local health departments or agencies;
  4. community mental health centers;
  5. not-for-profit hospitals;
  6. rural health clinics;
  7. skilled nursing facilities; and
  8. a combination of health care providers consisting of one or more entities falling into the first seven categories.

Please contact your primary BMD Healthcare & Hospital Law Group attorney if you have any questions regarding the Rural Health Care Program, this additional funding and how to apply for the use of funds, or any other general healthcare questions.


Effective December 12, 2024: Key Updates to Ohio Medicaid Rules for CPC and CMC Programs

Ohio Medicaid has amended rules for the Comprehensive Primary Care (CPC) and Comprehensive Maternal Care (CMC) programs, effective December 12, 2024. Key updates include expanded provider eligibility, stricter cultural competency training timelines, new clinical quality metrics, and changes to maternal care requirements.

Ohio Medicaid Extends Timely Filing Deadline Until 2025

The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.

Hurry Up, STOP. . .Has CTA Been Struck Down By Courts?

Following a recent case in Texas, uncertainty has arisen regarding whether clients should file "beneficial owners" reports. This is a result of the Federal Government enjoined from enforcing the CTA. Contact your BMD Member Blake Gerney to find out how this affects you.

DEA and HHS Issue its Third Extension of Telemedicine Flexibilities through 2025

The DEA and U.S. Department of Health and Human Services (HHS) have extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025. This extension builds on temporary exceptions made in 2020 due to COVID-19, allowing providers to prescribe Schedule II-V controlled substances based on a telemedicine evaluation alone. The extension ensures continued patient access to necessary prescriptions and provides time for providers to comply with future regulations.